While few studies have assessed the impact of PPARγ agonists on skeletal muscle inflammation and metabolism during inflammatory disorders such as sepsis, there has been some work surrounding the protective effects of PPARγ on myocardial dysfunction in sepsis. This evidence concerns the gene PPARG and Sepsis.